Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Intra-articular Hyaluronate Injection for Adhesive Capsulitis
NCT05983081Completed
- Sponsor
- Tri-Service General Hospital
- Start
- Aug 2023
- Primary completion
- Aug 2024
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of hyaluronic acid in adhesive capsulitis (AC) (2 arms), sponsored by Tri-Service General Hospital. Primary endpoint: Shoulder Pain and Disability Index at 26 weeks. Started Aug 2023; status: completed.
02
Drugs
hyaluronic acid
03
Conditions
adhesive capsulitis (AC)
Beyond the preview
Go deeper on NCT05983081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05983081.